Risk Factors for Colonization or Infection With Carbapenem-Resistant Enterobacteriaceae in Children
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age29-18
SponsorChildren's Hospital of Fudan University
About this trial
Carbapenem-resistant Enterobacteriaceae (CRE) are increasingly identified in children in China. Pediatric intensive care unit (PICU) is the high-risk area. However, data on the epidemiology of CRE in hospitalized children in PICU are limited. The objectives of this study are to characterize the risk factors for colonization or infection with CRE and describe the microbiologic characteristics of pediatric CRE isolates. The investigators will perform a single retrospective study from January 2018 to December 2019 at PICU of Children's Hospital of Fudan University .
Eligibility criteria
Qualifiers
All children hospitalized in PICU of Children's Hospital of Fudan University from January 2018 to December 2019.
Disqualifiers
discharge within 48 hours
patients had a positive culture for CRE before admission
incomplete clinical and demographic data
Trial design
Treatments tested in this trial
- Not listed
Trial groups
536 Participants
are grouped into 3 trial groupsSponsors and collaborators
Source ClinicalTrials.gov